MFIMFI
AMRI

Mesirow Financial Investment Management - Fixed Income’s Albany Molecular Research Inc AMRI Stock Holding History

Mesirow Financial Investment Management - Fixed Income’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-16,125
Closed -$227K – 173
2017
Q1 		$227K Hold
16,125
– – 0.02% 160
2016
Q4 		$302K Sell
16,125
-6,255
-28% -$106K 0.02% 200
2016
Q3 		$370K Hold
22,380
– – 0.02% 178
2016
Q2 		$300K Buy
+22,380
New +$326K 0.02% 181

Other funds holding AMRI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CCM
Chicago Capital Management Chicago, Illinois $112M AUM 76.54% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

Mesirow Financial Investment Management - Fixed Income's AMRI Position: Q2 2017 in Review

Mesirow Financial Investment Management - Fixed Income sold out of Albany Molecular Research Inc (AMRI) in Q2 2017, closing a stake of 16,125 shares — an estimated $227K sold.

Mesirow Financial Investment Management - Fixed Income first reported a position in AMRI in Q2 2016 and held it in 4 quarters. The position peaked at $370K in Q3 2016. 136 funds tracked by Wall St. Rank hold AMRI as of Q2 2017.

  • Mesirow Financial Investment Management - Fixed Income reported no remaining Albany Molecular Research Inc position as of Q2 2017 after selling out during the quarter.
  • Mesirow Financial Investment Management - Fixed Income sold 16,125 Albany Molecular Research Inc shares in Q2 2017, an estimated $227K.
  • Mesirow Financial Investment Management - Fixed Income first reported a position in Albany Molecular Research Inc in Q2 2016 and held it in 4 quarters.
  • Mesirow Financial Investment Management - Fixed Income's Albany Molecular Research Inc position peaked at $370K in Q3 2016.
  • 136 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q2 2017.

Based on Mesirow Financial Investment Management - Fixed Income's 13F filing for Q2 2017, filed 1 Aug 2017.